查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1379108

免疫调节剂市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Immunomodulators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球免疫调节剂市场规模达1,998亿美元。展望未来， IMARC Group预计到2028年市场规模将达到2,787亿美元，2022-2028年复合年增长率（CAGR）为5.7%。

免疫调节剂是一组用于改变针对传染病、免疫缺陷和抗体转移改变的免疫反应的药物。这些药物通常包括单株抗体、细胞激素、左旋咪唑和卡介苗（BCG）。它们广泛用于治疗癌症、气喘、肿瘤、遗传性血管性水肿和自体免疫疾病，如天疱疮、红斑性狼疮、过敏和类风湿关节炎。如今，一些医疗保健提供者推荐免疫调节剂与其他药物（例如生物製剂）一起用于治疗发炎性肠道疾病（IBD）。

免疫调节剂市场趋势：

由于快速城市化、收入水平上涨以及加工食品消费的增加，个人不健康的生活方式导致全球慢性病盛行率显着上升。这进一步增加了对器官移植的需求，这对作为器官移植受者有前途的治疗剂的局部免疫调节剂的需求产生了积极影响。此外，人口老化的加剧和事故数量的增加也增加了器官衰竭的风险。因此，一些管理和非管理当局正在鼓励器官捐赠，这反过来又促进了全球局部免疫调节剂的销售。除此之外，发炎性肠道疾病和自体免疫疾病的盛行率不断上升也推动了市场的成长。免疫调节剂也用于联合治疗，以减少对类固醇的长期需求，防止復发，并治疗对抗生素无反应的疾病。此外，包括氟伏沙明、托珠单抗和巴瑞替尼合併瑞德西韦在内的多种免疫调节剂正在用于治疗冠状病毒病 (COVID-19) 住院患者。除此之外，一些候选产品目前正处于后期临床试验阶段。这些产品的开发预计将扩大免疫调节剂在治疗各种危及生命的疾病方面的应用。

本报告回答的关键问题：

  • 迄今为止，全球免疫调节剂市场表现如何，未来几年将如何表现？
  • COVID-19 对全球免疫调节剂市场有何影响？
  • 主要区域市场有哪些？
  • 基于产品的市场区隔是什么？
  • 基于应用程式的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球免疫调节剂市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球免疫调节剂市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 免疫抑制剂
    • 市场走向
    • 关键环节
      • 抗体
      • 钙调磷酸酶抑制剂
      • 糖皮质激素
      • 抗代谢药
      • 其他的
    • 市场预测
  • 免疫增强剂
    • 市场走向
    • 关键环节
      • 疫苗
      • 抗体
      • 其他的
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 肿瘤学
    • 市场走向
    • 市场预测
  • 呼吸系统
    • 市场走向
    • 市场预测
  • 爱滋病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Amgen Inc.
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
Product Code: SR112023A4055

Abstract

The global immunomodulators market size reached US$ 199.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 278.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2022-2028.

Immunomodulators are a group of drugs used to modify an immune response against infectious diseases, immunodeficiency, and alterations in antibody transfer. These drugs generally include monoclonal antibodies, cytokines, levamisole, and Bacillus Calmette-Guerin (BCG). They are widely used to treat cancer, asthma, tumors, hereditary angioedema, and autoimmune disorders like pemphigus, lupus, allergies, and rheumatoid arthritis. Nowadays, several healthcare providers are recommending immunomodulators with other agents, such as biologics, for managing inflammatory bowel disease (IBD).

Immunomodulators Market Trends:

The unhealthy lifestyles of individuals on account of rapid urbanization, inflating income levels, and the increasing consumption of processed food products has led to a significant rise in the prevalence of chronic diseases worldwide. This is further escalating the need for organ transplantation, which is positively influencing the demand for topical immunomodulators as a promising therapeutic agent in organ transplant recipients. Moreover, the rising aging population and the growing number of accidents are also increasing the risk of organ failure. Consequently, several governing and non-governing authorities are encouraging organ donation, which, in turn, is boosting the sales of topical immunomodulators worldwide. Apart from this, the increasing prevalence of IBD and autoimmune disorders is bolstering the market growth. Immunomodulators are also utilized in combination therapy to decrease the long-term need for steroids and prevent recurring flares and treat diseases that do not respond to antibiotics. Furthermore, several immunomodulators, including Fluvoxamine, Tocilizumab, and Baricitinib with Remdesivir, are finding application for treating hospitalized patients with coronavirus disease (COVID-19). Besides this, several product candidates are currently in late-stage clinical trials. The development of these products is anticipated to expand the applications of immunomodulators for treating various life-threatening diseases.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunomodulators market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and application.

Breakup by Product:

Immunosuppressants

Antibodies

Calcineurin Inhibitors

Glucocorticoids

Antimetabolites

Others

Immunostimulants

Vaccines

Antibodies

Others

Breakup by Application:

Oncology

Respiratory

HIV

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.

Key Questions Answered in This Report:

  • How has the global immunomodulators market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunomodulators market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunomodulators market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunomodulators Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Immunosuppressants
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Antibodies
      • 6.1.2.2 Calcineurin Inhibitors
      • 6.1.2.3 Glucocorticoids
      • 6.1.2.4 Antimetabolites
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Immunostimulants
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Vaccines
      • 6.2.2.2 Antibodies
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Respiratory
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 HIV
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amgen Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biogen Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bristol-Myers Squibb Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Eli Lilly and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Johnson & Johnson
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Merck & Co. Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Pfizer Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunomodulators Market: Major Drivers and Challenges
  • Figure 2: Global: Immunomodulators Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Immunomodulators Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Immunomodulators Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Immunomodulators Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Immunomodulators Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Immunomodulators (Immunosuppressants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Immunomodulators (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Immunomodulators (Immunostimulants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Immunomodulators (Immunostimulants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Immunomodulators (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Immunomodulators (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Immunomodulators (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Immunomodulators (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Immunomodulators (HIV) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Immunomodulators (HIV) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Immunomodulators (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Immunomodulators (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: North America: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: North America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: United States: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: United States: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Canada: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Canada: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Asia-Pacific: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Asia-Pacific: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: China: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: China: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Japan: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Japan: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: India: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: India: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: South Korea: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: South Korea: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Australia: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Australia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Indonesia: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Indonesia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Others: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Europe: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Europe: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Germany: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Germany: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: France: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: France: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United Kingdom: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United Kingdom: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Italy: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Italy: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Spain: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Spain: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Russia: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Russia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Latin America: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Latin America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Brazil: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Brazil: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Mexico: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Mexico: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Immunomodulators Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Global: Immunomodulators Industry: SWOT Analysis
  • Figure 69: Global: Immunomodulators Industry: Value Chain Analysis
  • Figure 70: Global: Immunomodulators Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunomodulators Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Immunomodulators Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Immunomodulators Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Immunomodulators Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Immunomodulators Market: Competitive Structure
  • Table 6: Global: Immunomodulators Market: Key Players